Genesem Inc. (KOSDAQ:217190)
South Korea · Delayed Price · Currency is KRW 8,910.00
-40.00 (-0.45%)
At close: Sep 17, 2025
Genesem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 56,696 | 68,738 | 56,454 | 59,603 | 59,727 | 41,942 |
Other Revenue | -0 | -0 | - | - | - | - |
| 56,696 | 68,738 | 56,454 | 59,603 | 59,727 | 41,942 | |
Revenue Growth (YoY) | -21.79% | 21.76% | -5.28% | -0.21% | 42.41% | - |
Cost of Revenue | 34,959 | 39,752 | 36,627 | 35,601 | 39,109 | 30,204 |
Gross Profit | 21,736 | 28,986 | 19,827 | 24,002 | 20,619 | 11,738 |
Selling, General & Admin | 11,444 | 14,790 | 10,573 | 10,160 | 10,280 | 8,183 |
Research & Development | 5,851 | 5,693 | 4,385 | 4,161 | 3,583 | 2,975 |
Other Operating Expenses | 284.56 | 266.44 | 272.35 | 259.36 | 287.43 | 292.4 |
Operating Expenses | 19,021 | 22,445 | 16,265 | 15,484 | 14,985 | 12,782 |
Operating Income | 2,715 | 6,541 | 3,562 | 8,519 | 5,633 | -1,044 |
Interest Expense | -814.38 | -879.04 | -876.24 | -665.08 | -540.98 | -490.43 |
Interest & Investment Income | 421.02 | 401.21 | 320.22 | 157.35 | 18.89 | 17.17 |
Currency Exchange Gain (Loss) | -516.32 | 1,119 | 85.02 | 473.2 | 349.11 | -114.73 |
Other Non Operating Income (Expenses) | 86.17 | 3.85 | -7.44 | -103.38 | -139.39 | 524.93 |
EBT Excluding Unusual Items | 1,892 | 7,187 | 3,083 | 8,381 | 5,321 | -1,108 |
Gain (Loss) on Sale of Investments | 23.1 | 23.1 | 30.38 | 17.23 | 11.55 | 6.38 |
Gain (Loss) on Sale of Assets | 7 | -17.85 | - | - | 0.77 | 37.43 |
Asset Writedown | - | - | - | -15 | - | -64.39 |
Pretax Income | 1,922 | 7,192 | 3,114 | 8,383 | 5,333 | -1,128 |
Income Tax Expense | 152.26 | 1,071 | -482.29 | -3,807 | 90.66 | -69.6 |
Earnings From Continuing Operations | 1,770 | 6,121 | 3,596 | 12,190 | 5,242 | -1,059 |
Minority Interest in Earnings | -30.73 | -36.91 | 129.32 | 43.22 | 0.13 | - |
Net Income | 1,739 | 6,084 | 3,725 | 12,233 | 5,243 | -1,059 |
Net Income to Common | 1,739 | 6,084 | 3,725 | 12,233 | 5,243 | -1,059 |
Net Income Growth | -78.20% | 63.31% | -69.55% | 133.34% | - | - |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 9 |
EPS (Basic) | 198.29 | 693.79 | 424.82 | 1395.01 | 597.84 | -120.71 |
EPS (Diluted) | 198.29 | 693.79 | 424.82 | 1395.01 | 597.84 | -120.71 |
EPS Growth | -78.20% | 63.31% | -69.55% | 133.34% | - | - |
Free Cash Flow | 1,950 | 8,578 | 2,759 | 8,250 | 3,577 | -4,569 |
Free Cash Flow Per Share | 222.32 | 978.22 | 314.65 | 940.75 | 407.85 | -521.00 |
Dividend Per Share | 75.000 | 75.000 | - | - | - | - |
Gross Margin | 38.34% | 42.17% | 35.12% | 40.27% | 34.52% | 27.98% |
Operating Margin | 4.79% | 9.52% | 6.31% | 14.29% | 9.43% | -2.49% |
Profit Margin | 3.07% | 8.85% | 6.60% | 20.52% | 8.78% | -2.52% |
Free Cash Flow Margin | 3.44% | 12.48% | 4.89% | 13.84% | 5.99% | -10.89% |
EBITDA | 3,959 | 7,835 | 4,779 | 9,715 | 6,828 | 48.31 |
EBITDA Margin | 6.98% | 11.40% | 8.46% | 16.30% | 11.43% | 0.11% |
D&A For EBITDA | 1,244 | 1,293 | 1,217 | 1,196 | 1,195 | 1,093 |
EBIT | 2,715 | 6,541 | 3,562 | 8,519 | 5,633 | -1,044 |
EBIT Margin | 4.79% | 9.52% | 6.31% | 14.29% | 9.43% | -2.49% |
Effective Tax Rate | 7.92% | 14.89% | - | - | 1.70% | - |
Advertising Expenses | - | 206.01 | 68.25 | 64.28 | 14.84 | 6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.